{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:30:30Z","timestamp":1793039430220,"version":"4.5.0"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/nrcardio.2015.169","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T11:04:06Z","timestamp":1446548646000},"page":"167-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":366,"title":["Regulatory T cells in cardiovascular diseases"],"prefix":"10.1038","volume":"13","author":[{"given":"Xiao","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,3]]},"reference":[{"key":"BFnrcardio2015169_CR1","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20030152","volume":"198","author":"W Chen","year":"2003","unstructured":"Chen, W. et al. Conversion of peripheral CD4+CD25\u2212 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875\u20131886 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnrcardio2015169_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330\u2013336 (2003).","journal-title":"Nat. Immunol."},{"key":"BFnrcardio2015169_CR3","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","volume":"38","author":"P Libby","year":"2013","unstructured":"Libby, P., Lichtman, A. H. & Hansson, G. K. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 38, 1092\u20131104 (2013).","journal-title":"Immunity"},{"key":"BFnrcardio2015169_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni1178","volume":"6","author":"S Sakaguchi","year":"2005","unstructured":"Sakaguchi, S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345\u2013352 (2005).","journal-title":"Nat. Immunol."},{"key":"BFnrcardio2015169_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1084\/jem.20040685","volume":"201","author":"L Fahlen","year":"2005","unstructured":"Fahlen, L. et al. T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 201, 737\u2013746 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrcardio2015169_CR6","doi-asserted-by":"publisher","first-page":"10878","DOI":"10.1073\/pnas.1834400100","volume":"100","author":"EA Green","year":"2003","unstructured":"Green, E. A., Gorelik, L., McGregor, C. M., Tran, E. H. & Flavell, R. A. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc. Natl Acad. Sci. USA 100, 10878\u201310883 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio2015169_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.192.2.295","volume":"192","author":"S Read","year":"2000","unstructured":"Read, S., Malmstrom, V. & Powrie, F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295\u2013302 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnrcardio2015169_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/HYPERTENSIONAHA.114.03950","volume":"64","author":"X Meng","year":"2014","unstructured":"Meng, X. et al. Regulatory T cells prevent angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E knockout mice. Hypertension 64, 875\u2013882 (2014).","journal-title":"Hypertension"},{"key":"BFnrcardio2015169_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.immuni.2007.03.014","volume":"26","author":"MO Li","year":"2007","unstructured":"Li, M. O., Wan, Y. Y. & Flavell, R. A. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26, 579\u2013591 (2007).","journal-title":"Immunity"},{"key":"BFnrcardio2015169_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1084\/jem.194.5.629","volume":"194","author":"K Nakamura","year":"2001","unstructured":"Nakamura, K., Kitani, A. & Strober, W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194, 629\u2013644 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnrcardio2015169_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1359-6101(03)00003-0","volume":"14","author":"W Chen","year":"2003","unstructured":"Chen, W. & Wahl, S. M. TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression. Cytokine Growth Factor Rev. 14, 85\u201389 (2003).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnrcardio2015169_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1365-2567.2006.02346.x","volume":"118","author":"HJ Kim","year":"2006","unstructured":"Kim, H. J., Hwang, S. J., Kim, B. K., Jung, K. C. & Chung, D. H. NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells. Immunology 118, 101\u2013111 (2006).","journal-title":"Immunology"},{"key":"BFnrcardio2015169_CR13","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1161\/01.RES.85.8.e17","volume":"85","author":"Z Mallat","year":"1999","unstructured":"Mallat, Z. et al. Protective role of interleukin-10 in atherosclerosis. Circ. Res. 85, e17\u2013e24 (1999).","journal-title":"Circ. Res."},{"key":"BFnrcardio2015169_CR14","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1161\/01.ATV.19.12.2847","volume":"19","author":"LJ Pinderski Oslund","year":"1999","unstructured":"Pinderski Oslund, L. J. et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 19, 2847\u20132853 (1999).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio2015169_CR15","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1016\/j.ijcard.2013.03.026","volume":"168","author":"X Meng","year":"2013","unstructured":"Meng, X. et al. Regulatory T cells prevent plaque disruption in apolipoprotein E-knockout mice. Int. J. Cardiol. 168, 2684\u20132692 (2013).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio2015169_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","volume":"450","author":"LW Collison","year":"2007","unstructured":"Collison, L. W. et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566\u2013569 (2007).","journal-title":"Nature"},{"key":"BFnrcardio2015169_CR17","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni.1952","volume":"11","author":"LW Collison","year":"2010","unstructured":"Collison, L. W. et al. IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11, 1093\u20131101 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnrcardio2015169_CR18","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.4049\/jimmunol.172.8.4676","volume":"172","author":"N Misra","year":"2004","unstructured":"Misra, N., Bayry, J., Lacroix-Desmazes, S., Kazatchkine, M. D. & Kaveri, S. V. Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 172, 4676\u20134680 (2004).","journal-title":"J. Immunol."},{"key":"BFnrcardio2015169_CR19","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1074-7613(03)00327-3","volume":"19","author":"P Serra","year":"2003","unstructured":"Serra, P. et al. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. Immunity 19, 877\u2013889 (2003).","journal-title":"Immunity"},{"key":"BFnrcardio2015169_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1084\/jem.192.2.303","volume":"192","author":"T Takahashi","year":"2000","unstructured":"Takahashi, T. et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303\u2013310 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnrcardio2015169_CR21","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1126\/science.1202947","volume":"332","author":"OS Qureshi","year":"2011","unstructured":"Qureshi, O. S. et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332, 600\u2013603 (2011).","journal-title":"Science"},{"key":"BFnrcardio2015169_CR22","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.4049\/jimmunol.180.9.5916","volume":"180","author":"B Liang","year":"2008","unstructured":"Liang, B. et al. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J. Immunol. 180, 5916\u20135926 (2008).","journal-title":"J. Immunol."},{"key":"BFnrcardio2015169_CR23","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/ni846","volume":"3","author":"U Grohmann","year":"2002","unstructured":"Grohmann, U. et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3, 1097\u20131101 (2002).","journal-title":"Nat. Immunol."},{"key":"BFnrcardio2015169_CR24","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/ni1003","volume":"4","author":"F Fallarino","year":"2003","unstructured":"Fallarino, F. et al. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4, 1206\u20131212 (2003).","journal-title":"Nat. Immunol."},{"key":"BFnrcardio2015169_CR25","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino, G. et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110, 1225\u20131232 (2007).","journal-title":"Blood"},{"key":"BFnrcardio2015169_CR26","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio, S. et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257\u20131265 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnrcardio2015169_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1182\/blood-2007-03-081646","volume":"111","author":"PE Zarek","year":"2008","unstructured":"Zarek, P. E. et al. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111, 251\u2013259 (2008).","journal-title":"Blood"},{"key":"BFnrcardio2015169_CR28","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ni1536","volume":"8","author":"P Pandiyan","year":"2007","unstructured":"Pandiyan, P., Zheng, L., Ishihara, S., Reed, J. & Lenardo, M. J. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8, 1353\u20131362 (2007).","journal-title":"Nat. Immunol."},{"key":"BFnrcardio2015169_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.188.2.287","volume":"188","author":"AM Thornton","year":"1998","unstructured":"Thornton, A. M. & Shevach, E. M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287\u2013296 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnrcardio2015169_CR30","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1002\/eji.200526065","volume":"35","author":"J Haas","year":"2005","unstructured":"Haas, J. et al. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35, 3343\u20133352 (2005).","journal-title":"Eur. J. Immunol."},{"key":"BFnrcardio2015169_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1189\/jlb.0607436","volume":"83","author":"EN Nolte-'t Hoen","year":"2008","unstructured":"Nolte-'t Hoen, E. N. et al. Identification and monitoring of effector and regulatory T cells during experimental arthritis based on differential expression of CD25 and CD134. J. Leukoc. Biol. 83, 112\u2013121 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrcardio2015169_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3109\/08830180903349644","volume":"29","author":"F Zhou","year":"2010","unstructured":"Zhou, F. Perforin: more than just a pore-forming protein. Int. Rev. Immunol 29, 56\u201376 (2010).","journal-title":"Int. Rev. Immunol"},{"key":"BFnrcardio2015169_CR33","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.4049\/jimmunol.174.4.1783","volume":"174","author":"DC Gondek","year":"2005","unstructured":"Gondek, D. C., Lu, L. F., Quezada, S. A., Sakaguchi, S. & Noelle, R. J. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174, 1783\u20131786 (2005).","journal-title":"J. Immunol."},{"key":"BFnrcardio2015169_CR34","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","volume":"27","author":"X Cao","year":"2007","unstructured":"Cao, X. et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27, 635\u2013646 (2007).","journal-title":"Immunity"},{"key":"BFnrcardio2015169_CR35","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/ni735","volume":"2","author":"RS Bystry","year":"2001","unstructured":"Bystry, R. S., Aluvihare, V., Welch, K. A., Kallikourdis, M. & Betz, A. G. B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immunol. 2, 1126\u20131132 (2001).","journal-title":"Nat. Immunol."},{"key":"BFnrcardio2015169_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1074-7613(02)00298-4","volume":"16","author":"SJ Seo","year":"2002","unstructured":"Seo, S. J. et al. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity 16, 535\u2013546 (2002).","journal-title":"Immunity"},{"key":"BFnrcardio2015169_CR37","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.4049\/jimmunol.175.7.4180","volume":"175","author":"HW Lim","year":"2005","unstructured":"Lim, H. W., Hillsamer, P., Banham, A. H. & Kim, C. H. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J. Immunol. 175, 4180\u20134183 (2005).","journal-title":"J. Immunol."},{"key":"BFnrcardio2015169_CR38","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.4049\/jimmunol.0901163","volume":"183","author":"N Iikuni","year":"2009","unstructured":"Iikuni, N., Lourenco, E. V., Hahn, B. H. & La Cava, A. Cutting edge: regulatory T cells directly suppress B cells in systemic lupus erythematosus. J. Immunol. 183, 1518\u20131522 (2009).","journal-title":"J. Immunol."},{"key":"BFnrcardio2015169_CR39","doi-asserted-by":"publisher","first-page":"10468","DOI":"10.1073\/pnas.1201131109","volume":"109","author":"J Gotot","year":"2012","unstructured":"Gotot, J. et al. Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo. Proc. Natl Acad. Sci. USA 109, 10468\u201310473 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio2015169_CR40","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature06796","volume":"451","author":"DJ Rader","year":"2008","unstructured":"Rader, D. J. & Daugherty, A. Translating molecular discoveries into new therapies for atherosclerosis. Nature 451, 904\u2013913 (2008).","journal-title":"Nature"},{"key":"BFnrcardio2015169_CR41","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1172\/JCI57175","volume":"123","author":"A Chaudhry","year":"2013","unstructured":"Chaudhry, A. & Rudensky, A. Y. Control of inflammation by integration of environmental cues by regulatory T cells. J. Clin. Invest. 123, 939\u2013944 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2015169_CR42","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1172\/JCI72477","volume":"123","author":"W Chen","year":"2013","unstructured":"Chen, W. Regulatory T cells use \u201cItch\u201d to control asthma. J. Clin. Invest. 123, 4576\u20134578 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2015169_CR43","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1161\/ATVBAHA.110.210492","volume":"30","author":"S He","year":"2010","unstructured":"He, S., Li, M., Ma, X., Lin, J. & Li, D. CD4+CD25+Foxp3+ regulatory T cells protect the proinflammatory activation of human umbilical vein endothelial cells. Arterioscler. Thromb. Vasc. Biol. 30, 2621\u20132630 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio2015169_CR44","first-page":"2","volume":"2012","author":"JL Pastrana","year":"2012","unstructured":"Pastrana, J. L. et al. Regulatory T cells and atherosclerosis. J. Clin. Exp. Cardiolog. 2012, 2 (2012).","journal-title":"J. Clin. Exp. Cardiolog."},{"key":"BFnrcardio2015169_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2459\/JCM.0b013e3283641b9c","volume":"15","author":"Z Wang","year":"2014","unstructured":"Wang, Z. et al. Effect of hyperlipidemia on Foxp3 expression in apolipoprotein E-knockout mice. J. Cardiovasc. Med. (Hagerstown) 15, 273\u2013279 (2014).","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"BFnrcardio2015169_CR46","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/01.ATV.0000259365.31469.89","volume":"27","author":"A Mor","year":"2007","unstructured":"Mor, A. et al. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 893\u2013900 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio2015169_CR47","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nm1343","volume":"12","author":"H Ait-Oufella","year":"2006","unstructured":"Ait-Oufella, H. et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12, 178\u2013180 (2006).","journal-title":"Nat. Med."},{"key":"BFnrcardio2015169_CR48","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1161\/01.CIR.0000089083.61317.A1","volume":"108","author":"Z Mallat","year":"2003","unstructured":"Mallat, Z. et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 108, 1232\u20131237 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio2015169_CR49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/cvr\/cvp182","volume":"84","author":"J Feng","year":"2009","unstructured":"Feng, J. et al. Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-\/- mice. Cardiovasc. Res. 84, 155\u2013163 (2009).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2015169_CR50","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s10875-012-9699-7","volume":"32","author":"Y Zhong","year":"2012","unstructured":"Zhong, Y. et al. CD4+LAP+ and CD4+CD25+Foxp3+ regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-\/- mice. J. Clin. Immunol. 32, 1104\u20131117 (2012).","journal-title":"J. Clin. Immunol."},{"key":"BFnrcardio2015169_CR51","doi-asserted-by":"publisher","first-page":"598","DOI":"10.2119\/molmed.2011.00471","volume":"18","author":"X Meng","year":"2012","unstructured":"Meng, X. et al. Statins induce the accumulation of regulatory T cells in atherosclerotic plaque. Mol. Med. 18, 598\u2013605 (2012).","journal-title":"Mol. Med."},{"key":"BFnrcardio2015169_CR52","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.atherosclerosis.2007.07.031","volume":"197","author":"K Mausner-Fainberg","year":"2008","unstructured":"Mausner-Fainberg, K. et al. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Atherosclerosis 197, 829\u2013839 (2008).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio2015169_CR53","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s10517-009-0595-y","volume":"147","author":"VO Sokolov","year":"2009","unstructured":"Sokolov, V. O., Krasnikova, T. L., Prokofieva, L. V., Kukhtina, N. B. & Arefieva, T. I. Expression of markers of regulatory CD4+CD25+foxp3+ cells in atherosclerotic plaques of human coronary arteries. Bull. Exp. Biol. Med. 147, 726\u2013729 (2009).","journal-title":"Bull. Exp. Biol. Med."},{"key":"BFnrcardio2015169_CR54","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1371\/journal.pone.0000779","volume":"2","author":"OJ de Boer","year":"2007","unstructured":"de Boer, O. J., van der Meer, J. J., Teeling, P., van der Loos, C. M. & van der Wal, A. C. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS ONE 2, e779 (2007).","journal-title":"PLoS ONE"},{"key":"BFnrcardio2015169_CR55","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00011-012-0510-2","volume":"61","author":"ZD Liu","year":"2012","unstructured":"Liu, Z. D. et al. Increased Th17 cell frequency concomitant with decreased Foxp3+ Treg cell frequency in the peripheral circulation of patients with carotid artery plaques. Inflamm. Res. 61, 1155\u20131165 (2012).","journal-title":"Inflamm. Res."},{"key":"BFnrcardio2015169_CR56","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2013.06.014","volume":"230","author":"B Dietel","year":"2013","unstructured":"Dietel, B. et al. Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells. Atherosclerosis 230, 92\u201399 (2013).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio2015169_CR57","doi-asserted-by":"publisher","first-page":"364710","DOI":"10.1155\/2015\/364710","volume":"2015","author":"I Rohm","year":"2015","unstructured":"Rohm, I. et al. Decreased regulatory T cells in vulnerable atherosclerotic lesions: imbalance between pro- and anti-inflammatory cells in atherosclerosis. Mediators Inflamm. 2015, 364710 (2015).","journal-title":"Mediators Inflamm."},{"key":"BFnrcardio2015169_CR58","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.atherosclerosis.2012.03.016","volume":"222","author":"J George","year":"2012","unstructured":"George, J. et al. Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques. Atherosclerosis 222, 519\u2013523 (2012).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio2015169_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","volume":"127","author":"X Cheng","year":"2008","unstructured":"Cheng, X. et al. The Th17\/Treg imbalance in patients with acute coronary syndrome. Clin. Immunol. 127, 89\u201397 (2008).","journal-title":"Clin. Immunol."},{"key":"BFnrcardio2015169_CR60","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1093\/eurheartj\/ehl222","volume":"27","author":"A Mor","year":"2006","unstructured":"Mor, A., Luboshits, G., Planer, D., Keren, G. & George, J. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur. Heart J. 27, 2530\u20132537 (2006).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2015169_CR61","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1253\/circj.CJ-14-0644","volume":"78","author":"T Emoto","year":"2014","unstructured":"Emoto, T. et al. Regulatory\/effector T-cell ratio is reduced in coronary artery disease. Circ. J. 78, 2935\u20132941 (2014).","journal-title":"Circ. J."},{"key":"BFnrcardio2015169_CR62","doi-asserted-by":"publisher","first-page":"34157","DOI":"10.1074\/jbc.M112.382978","volume":"287","author":"WC Zhang","year":"2012","unstructured":"Zhang, W. C. et al. Impaired thymic export and increased apoptosis account for regulatory T cell defects in patients with non-ST segment elevation acute coronary syndrome. J. Biol. Chem. 287, 34157\u201334166 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFnrcardio2015169_CR63","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/ATVBAHA.110.206813","volume":"30","author":"E Ammirati","year":"2010","unstructured":"Ammirati, E. et al. Circulating CD4+CD25hiCD127lo regulatory T-Cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30, 1832\u20131841 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio2015169_CR64","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P Libby","year":"2011","unstructured":"Libby, P., Ridker, P. M. & Hansson, G. K. Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317\u2013325 (2011).","journal-title":"Nature"},{"key":"BFnrcardio2015169_CR65","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1172\/JCI63891","volume":"123","author":"R Klingenberg","year":"2013","unstructured":"Klingenberg, R. et al. Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J. Clin. Invest. 123, 1323\u20131334 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2015169_CR66","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2011.04.029","volume":"218","author":"AC Foks","year":"2011","unstructured":"Foks, A. C. et al. Differential effects of regulatory T cells on the initiation and regression of atherosclerosis. Atherosclerosis 218, 53\u201360 (2011).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio2015169_CR67","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1194\/jlr.D000497","volume":"51","author":"J Lin","year":"2010","unstructured":"Lin, J. et al. The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation. J. Lipid Res. 51, 1208\u20131217 (2010).","journal-title":"J. Lipid Res."},{"key":"BFnrcardio2015169_CR68","doi-asserted-by":"publisher","first-page":"19446","DOI":"10.1073\/pnas.0706832104","volume":"104","author":"MM Tiemessen","year":"2007","unstructured":"Tiemessen, M. M. et al. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes\/macrophages. Proc. Natl Acad. Sci. USA 104, 19446\u201319451 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio2015169_CR69","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1172\/JCI64617","volume":"123","author":"M Subramanian","year":"2013","unstructured":"Subramanian, M., Thorp, E., Hansson, G. K. & Tabas, I. Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs. J. Clin. Invest. 123, 179\u2013188 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2015169_CR70","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1161\/hh2201.099415","volume":"89","author":"Z Mallat","year":"2001","unstructured":"Mallat, Z. et al. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ. Res. 89, 930\u2013934 (2001).","journal-title":"Circ. Res."},{"key":"BFnrcardio2015169_CR71","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1172\/JCI18607","volume":"112","author":"AK Robertson","year":"2003","unstructured":"Robertson, A. K. et al. Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J. Clin. Invest. 112, 1342\u20131350 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2015169_CR72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/BF03402102","volume":"9","author":"G Caligiuri","year":"2003","unstructured":"Caligiuri, G. et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol. Med. 9, 10\u201317 (2003).","journal-title":"Mol. Med."},{"key":"BFnrcardio2015169_CR73","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2005.10.029","volume":"188","author":"Y Liu","year":"2006","unstructured":"Liu, Y. et al. Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10. Atherosclerosis 188, 19\u201327 (2006).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio2015169_CR74","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2174\/1381612820666141014123810","volume":"21","author":"YV Bobryshev","year":"2015","unstructured":"Bobryshev, Y. V., Sobenin, I. A., Orekhov, A. N. & Chistiakov, D. A. Novel anti-inflammatory interleukin-35 as an emerging target for antiatherosclerotic therapy. Curr. Pharm. Des. 21, 1147\u20131151 (2015).","journal-title":"Curr. Pharm. Des."},{"key":"BFnrcardio2015169_CR75","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1084\/jem.20100155","volume":"207","author":"H Ait-Oufella","year":"2010","unstructured":"Ait-Oufella, H. et al. B cell depletion reduces the development of atherosclerosis in mice. J. Exp. Med. 207, 1579\u20131587 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnrcardio2015169_CR76","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.4049\/jimmunol.1000033","volume":"185","author":"T Kyaw","year":"2010","unstructured":"Kyaw, T. et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J. Immunol. 185, 4410\u20134419 (2010).","journal-title":"J. Immunol."},{"key":"BFnrcardio2015169_CR77","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/ATVBAHA.114.303569","volume":"35","author":"D Tsiantoulas","year":"2015","unstructured":"Tsiantoulas, D., Sage, A. P., Mallat, Z. & Binder, C. J. Targeting B cells in atherosclerosis: closing the gap from bench to bedside. Arterioscler. Thromb. Vasc. Biol. 35, 296\u2013302 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio2015169_CR78","doi-asserted-by":"publisher","first-page":"H938","DOI":"10.1152\/ajpheart.00707.2009","volume":"298","author":"EC Viel","year":"2010","unstructured":"Viel, E. C., Lemarie, C. A., Benkirane, K., Paradis, P. & Schiffrin, E. L. Immune regulation and vascular inflammation in genetic hypertension. Am. J. Physiol. Heart Circ. Physiol. 298, H938\u2013H944 (2010).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio2015169_CR79","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1084\/jem.20070657","volume":"204","author":"TJ Guzik","year":"2007","unstructured":"Guzik, T. J. et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 204, 2449\u20132460 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnrcardio2015169_CR80","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ajpath.2010.11.034","volume":"178","author":"K Matrougui","year":"2011","unstructured":"Matrougui, K. et al. Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice. Am. J. Pathol. 178, 434\u2013441 (2011).","journal-title":"Am. J. Pathol."},{"key":"BFnrcardio2015169_CR81","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1097\/HJH.0b013e328362feb7","volume":"31","author":"M Kassan","year":"2013","unstructured":"Kassan, M., Wecker, A., Kadowitz, P., Trebak, M. & Matrougui, K. CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension. J. Hypertens. 31, 1939\u20131943 (2013).","journal-title":"J. Hypertens."},{"key":"BFnrcardio2015169_CR82","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1159\/000335759","volume":"28","author":"M Li","year":"2011","unstructured":"Li, M. et al. CD4+CD25+Foxp3+ regulatory T cells protect endothelial function impaired by oxidized low density lipoprotein via the KLF-2 transcription factor. Cell Physiol. Biochem. 28, 639\u2013648 (2011).","journal-title":"Cell Physiol. Biochem."},{"key":"BFnrcardio2015169_CR83","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1161\/HYPERTENSIONAHA.110.162917","volume":"57","author":"VL Chiasson","year":"2011","unstructured":"Chiasson, V. L. et al. FK506 binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension. Hypertension 57, 1167\u20131175 (2011).","journal-title":"Hypertension"},{"key":"BFnrcardio2015169_CR84","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.111.181123","volume":"59","author":"DA Kasal","year":"2012","unstructured":"Kasal, D. A. et al. T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension 59, 324\u2013330 (2012).","journal-title":"Hypertension"},{"key":"BFnrcardio2015169_CR85","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.110.162941","volume":"57","author":"T Barhoumi","year":"2011","unstructured":"Barhoumi, T. et al. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 57, 469\u2013476 (2011).","journal-title":"Hypertension"},{"key":"BFnrcardio2015169_CR86","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1161\/ATVBAHA.111.233262","volume":"31","author":"M Kassan","year":"2011","unstructured":"Kassan, M., Galan, M., Partyka, M., Trebak, M. & Matrougui, K. Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice. Arterioscler. Thromb. Vasc. Biol. 31, 2534\u20132542 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio2015169_CR87","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2013.12.004","volume":"233","author":"Z Liu","year":"2014","unstructured":"Liu, Z. et al. Treatment with telmisartan\/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17\/Treg functional imbalance in hypertensive patients with carotid atherosclerosis. Atherosclerosis 233, 291\u2013299 (2014).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio2015169_CR88","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1161\/CIRCULATIONAHA.108.832782","volume":"119","author":"H Kvakan","year":"2009","unstructured":"Kvakan, H. et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 119, 2904\u20132912 (2009).","journal-title":"Circulation"},{"key":"BFnrcardio2015169_CR89","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1097\/HJH.0b013e328349c62d","volume":"29","author":"P Kanellakis","year":"2011","unstructured":"Kanellakis, P., Dinh, T. N., Agrotis, A. & Bobik, A. CD4(+)CD25(+)Foxp3(+) regulatory T cells suppress cardiac fibrosis in the hypertensive heart. J. Hypertens. 29, 1820\u20131828 (2011).","journal-title":"J. Hypertens."},{"key":"BFnrcardio2015169_CR90","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1161\/ATVBAHA.113.301280","volume":"33","author":"H Ait-Oufella","year":"2013","unstructured":"Ait-Oufella, H. et al. Natural regulatory T cells limit angiotensin II-induced aneurysm formation and rupture in mice. Arterioscler. Thromb. Vasc. Biol. 33, 2374\u20132379 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio2015169_CR91","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1161\/HYPERTENSIONAHA.111.203521","volume":"61","author":"A Leibowitz","year":"2013","unstructured":"Leibowitz, A., Rehman, A., Paradis, P. & Schiffrin, E. L. Role of T regulatory lymphocytes in the pathogenesis of high-fructose diet-induced metabolic syndrome. Hypertension 61, 1316\u20131321 (2013).","journal-title":"Hypertension"},{"key":"BFnrcardio2015169_CR92","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/HYPERTENSIONAHA.114.04934","volume":"65","author":"K Yodoi","year":"2015","unstructured":"Yodoi, K. et al. Foxp3+ Regulatory T Cells play a protective role in angiotensin II-induced aortic aneurysm formation in mice. Hypertension 65, 889\u2013895 (2015).","journal-title":"Hypertension"},{"key":"BFnrcardio2015169_CR93","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/01.ATV.0000245819.32762.cb","volume":"26","author":"J Golledge","year":"2006","unstructured":"Golledge, J., Muller, J., Daugherty, A. & Norman, P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler. Thromb. Vasc. Biol. 26, 2605\u20132613 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio2015169_CR94","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1161\/ATVBAHA.109.200303","volume":"30","author":"M Yin","year":"2010","unstructured":"Yin, M. et al. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 30, 1825\u20131831 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio2015169_CR95","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/CIRCRESAHA.110.236927","volume":"109","author":"R Tamosiuniene","year":"2011","unstructured":"Tamosiuniene, R. et al. Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension. Circ. Res. 109, 867\u2013879 (2011).","journal-title":"Circ. Res."},{"key":"BFnrcardio2015169_CR96","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000024324","volume":"121","author":"M Miyata","year":"2000","unstructured":"Miyata, M. et al. Athymic nude rats develop severe pulmonary hypertension following monocrotaline administration. Int. Arch. Allergy Immunol. 121, 246\u2013252 (2000).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"BFnrcardio2015169_CR97","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-2172-12-67","volume":"12","author":"M Rabieyousefi","year":"2011","unstructured":"Rabieyousefi, M. et al. Indispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension. BMC Immunol. 12, 67 (2011).","journal-title":"BMC Immunol."},{"key":"BFnrcardio2015169_CR98","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4103\/2045-8932.105031","volume":"2","author":"MR Nicolls","year":"2012","unstructured":"Nicolls, M. R. et al. New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis. Pulm. Circ. 2, 434\u2013442 (2012).","journal-title":"Pulm. Circ."},{"key":"BFnrcardio2015169_CR99","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.tcm.2012.05.004","volume":"21","author":"R Tamosiuniene","year":"2011","unstructured":"Tamosiuniene, R. & Nicolls, M. R. Regulatory T cells and pulmonary hypertension. Trends Cardiovasc. Med. 21, 166\u2013171 (2011).","journal-title":"Trends Cardiovasc. Med."},{"key":"BFnrcardio2015169_CR100","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1165\/rcmb.2011-0015OC","volume":"47","author":"B Chen","year":"2012","unstructured":"Chen, B., Calvert, A. E., Meng, X. & Nelin, L. D. Pharmacologic agents elevating cAMP prevent arginase II expression and proliferation of pulmonary artery smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 47, 218\u2013226 (2012).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFnrcardio2015169_CR101","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.3892\/mmr.2014.3106","volume":"11","author":"Y Chu","year":"2015","unstructured":"Chu, Y., Xiangli, X. & Xiao, W. Regulatory T cells protect against hypoxia-induced pulmonary arterial hypertension in mice. Mol. Med. Rep. 11, 3181\u20133187 (2015).","journal-title":"Mol. Med. Rep."},{"key":"BFnrcardio2015169_CR102","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1159\/000111548","volume":"75","author":"S Ulrich","year":"2008","unstructured":"Ulrich, S., Nicolls, M. R., Taraseviciene, L., Speich, R. & Voelkel, N. Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension. Respiration 75, 272\u2013280 (2008).","journal-title":"Respiration"},{"key":"BFnrcardio2015169_CR103","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.rmed.2009.10.004","volume":"104","author":"ED Austin","year":"2010","unstructured":"Austin, E. D. et al. T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension. Respir. Med. 104, 454\u2013462 (2010).","journal-title":"Respir. Med."},{"key":"BFnrcardio2015169_CR104","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000114655","volume":"75","author":"F Perros","year":"2008","unstructured":"Perros, F., Cohen-Kaminsky, S. & Humbert, M. Understanding the role of CD4+CD25 (high) (so-called regulatory) T cells in idiopathic pulmonary arterial hypertension. Respiration 75, 253\u2013256 (2008).","journal-title":"Respiration"},{"key":"BFnrcardio2015169_CR105","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1183\/09031936.00159911","volume":"40","author":"A Huertas","year":"2012","unstructured":"Huertas, A. et al. Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension. Eur. Respir. J. 40, 895\u2013904 (2012).","journal-title":"Eur. Respir. J."},{"key":"BFnrcardio2015169_CR106","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2172-13-56","volume":"13","author":"HG Martinez","year":"2012","unstructured":"Martinez, H. G. et al. Important role of CCR2 in a murine model of coronary vasculitis. BMC Immunol. 13, 56 (2012).","journal-title":"BMC Immunol."},{"key":"BFnrcardio2015169_CR107","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12098-009-0031-3","volume":"76","author":"JC Burns","year":"2009","unstructured":"Burns, J. C. Kawasaki disease update. Indian J. Pediatr. 76, 71\u201376 (2009).","journal-title":"Indian J. Pediatr."},{"key":"BFnrcardio2015169_CR108","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2249.2010.04236.x","volume":"162","author":"S Jia","year":"2010","unstructured":"Jia, S., Li, C., Wang, G., Yang, J. & Zu, Y. The T helper type 17\/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin. Exp. Immunol. 162, 131\u2013137 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrcardio2015169_CR109","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/cei.12418","volume":"178","author":"FF Ni","year":"2014","unstructured":"Ni, F. F. et al. Regulatory T cell microRNA expression changes in children with acute Kawasaki disease. Clin. Exp. Immunol. 178, 384\u2013393 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrcardio2015169_CR110","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00431-013-1937-3","volume":"172","author":"Y Hirabayashi","year":"2013","unstructured":"Hirabayashi, Y. et al. Lack of CD4(+)CD25(+)FOXP3(+) regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease. Eur. J. Pediatr. 172, 833\u2013837 (2013).","journal-title":"Eur. J. Pediatr."},{"key":"BFnrcardio2015169_CR111","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1365-2249.2004.02506.x","volume":"137","author":"J Kimura","year":"2004","unstructured":"Kimura, J. et al. Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease. Clin. Exp. Immunol. 137, 444\u2013449 (2004).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrcardio2015169_CR112","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jpeds.2004.05.048","volume":"145","author":"K Furuno","year":"2004","unstructured":"Furuno, K. et al. CD25+CD4+ regulatory T cells in patients with Kawasaki disease. J. Pediatr. 145, 385\u2013390 (2004).","journal-title":"J. Pediatr."},{"key":"BFnrcardio2015169_CR113","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.4049\/jimmunol.179.8.5571","volume":"179","author":"A Kessel","year":"2007","unstructured":"Kessel, A. et al. Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function. J. Immunol. 179, 5571\u20135575 (2007).","journal-title":"J. Immunol."},{"key":"BFnrcardio2015169_CR114","doi-asserted-by":"publisher","first-page":"e113653","DOI":"10.1371\/journal.pone.0113653","volume":"9","author":"R Sharir","year":"2014","unstructured":"Sharir, R. et al. Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodeling. PLoS ONE 9, e113653 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrcardio2015169_CR115","doi-asserted-by":"publisher","first-page":"H1233","DOI":"10.1152\/ajpheart.00328.2014","volume":"307","author":"A Saxena","year":"2014","unstructured":"Saxena, A. et al. Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function. Am. J. Physiol. Heart Circ. Physiol. 307, H1233\u2013H1242 (2014).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio2015169_CR116","first-page":"53","volume":"9","author":"S Ghourbani Gazar","year":"2012","unstructured":"Ghourbani Gazar, S., Andalib, A., Hashemi, M. & Rezaei, A. CD4(+)Foxp3(+) Treg and its ICOS(+) subsets in patients with myocardial infarction. Iran J. Immunol. 9, 53\u201360 (2012).","journal-title":"Iran J. Immunol."},{"key":"BFnrcardio2015169_CR117","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1161\/ATVBAHA.112.251579","volume":"32","author":"M Wigren","year":"2012","unstructured":"Wigren, M. et al. Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke. Arterioscler. Thromb. Vasc. Biol. 32, 2000\u20132004 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio2015169_CR118","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCRESAHA.116.304072","volume":"116","author":"U Hofmann","year":"2015","unstructured":"Hofmann, U. & Frantz, S. Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction. Circ. Res. 116, 354\u2013367 (2015).","journal-title":"Circ. Res."},{"key":"BFnrcardio2015169_CR119","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00395-011-0232-6","volume":"107","author":"TT Tang","year":"2012","unstructured":"Tang, T. T. et al. Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res. Cardiol. 107, 232 (2012).","journal-title":"Basic Res. Cardiol."},{"key":"BFnrcardio2015169_CR120","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/CIRCRESAHA.115.303895","volume":"115","author":"J Weirather","year":"2014","unstructured":"Weirather, J. et al. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte\/macrophage differentiation. Circ. Res. 115, 55\u201367 (2014).","journal-title":"Circ. Res."},{"key":"BFnrcardio2015169_CR121","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.2353\/ajpath.2010.090759","volume":"176","author":"M Dobaczewski","year":"2010","unstructured":"Dobaczewski, M., Xia, Y., Bujak, M., Gonzalez-Quesada, C. & Frangogiannis, N. G. CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am. J. Pathol. 176, 2177\u20132187 (2010).","journal-title":"Am. J. Pathol."},{"key":"BFnrcardio2015169_CR122","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1536\/ihj.52.382","volume":"52","author":"K Matsumoto","year":"2011","unstructured":"Matsumoto, K. et al. Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice. Int. Heart J. 52, 382\u2013387 (2011).","journal-title":"Int. Heart J."},{"key":"BFnrcardio2015169_CR123","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1042\/CS20140672","volume":"128","author":"N Xia","year":"2015","unstructured":"Xia, N. et al. Activated regulatory T cells attenuate myocardial ischemia\/reperfusion injury through a CD39-dependent mechanism. Clin. Sci. 128, 679\u2013693 (2015).","journal-title":"Clin. Sci."},{"key":"BFnrcardio2015169_CR124","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/CIRCULATIONAHA.109.875583","volume":"120","author":"Y Zouggari","year":"2009","unstructured":"Zouggari, Y. et al. Regulatory T cells modulate postischemic neovascularization. Circulation 120, 1415\u20131425 (2009).","journal-title":"Circulation"},{"key":"BFnrcardio2015169_CR125","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/cvr\/cvu159","volume":"103","author":"R Sharir","year":"2014","unstructured":"Sharir, R. et al. Regulatory T cells influence blood flow recovery in experimental hindlimb ischaemia in an IL-10-dependent manner. Cardiovasc. Res. 103, 585\u2013596 (2014).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2015169_CR126","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1582-4934.2011.01300.x","volume":"16","author":"AA Hellingman","year":"2012","unstructured":"Hellingman, A. A. et al. A limited role for regulatory T cells in post-ischemic neovascularization. J. Cell. Mol. Med. 16, 328\u2013336 (2012).","journal-title":"J. Cell. Mol. Med."},{"key":"BFnrcardio2015169_CR127","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/01.CIR.0000079225.50817.71","volume":"108","author":"E Stabile","year":"2003","unstructured":"Stabile, E. et al. Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation 108, 205\u2013210 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio2015169_CR128","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jacc.2004.04.046","volume":"44","author":"H Niiyama","year":"2004","unstructured":"Niiyama, H. et al. Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization. J. Am. Coll. Cardiol. 44, 661\u2013666 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2015169_CR129","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1172\/JCI0213055","volume":"109","author":"K Sasaki","year":"2002","unstructured":"Sasaki, K. et al. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J. Clin. Invest. 109, 603\u2013611 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2015169_CR130","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/01.RES.87.6.448","volume":"87","author":"JS Silvestre","year":"2000","unstructured":"Silvestre, J. S. et al. Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ. Res. 87, 448\u2013452 (2000).","journal-title":"Circ. Res."},{"key":"BFnrcardio2015169_CR131","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.105.606509","volume":"114","author":"H Mahrholdt","year":"2006","unstructured":"Mahrholdt, H. et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114, 1581\u20131590 (2006).","journal-title":"Circulation"},{"key":"BFnrcardio2015169_CR132","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/vim.2006.19.133","volume":"19","author":"PE Tam","year":"2006","unstructured":"Tam, P. E. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol. 19, 133\u2013146 (2006).","journal-title":"Viral Immunol."},{"key":"BFnrcardio2015169_CR133","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2174\/187152811795564091","volume":"10","author":"K Watanabe","year":"2011","unstructured":"Watanabe, K. et al. Regulation of inflammation and myocardial fibrosis in experimental autoimmune myocarditis. Inflamm. Allergy Drug Targets 10, 218\u2013225 (2011).","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"BFnrcardio2015169_CR134","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0065-2776(08)00604-4","volume":"99","author":"D Cihakova","year":"2008","unstructured":"Cihakova, D. & Rose, N. R. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 99, 95\u2013114 (2008).","journal-title":"Adv. Immunol."},{"key":"BFnrcardio2015169_CR135","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.autrev.2004.08.009","volume":"3","author":"M Afanasyeva","year":"2004","unstructured":"Afanasyeva, M., Georgakopoulos, D. & Rose, N. R. Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun. Rev. 3, 476\u2013486 (2004).","journal-title":"Autoimmun. Rev."},{"key":"BFnrcardio2015169_CR136","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/cvr\/cvt246","volume":"101","author":"JH Lee","year":"2014","unstructured":"Lee, J. H. et al. Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis. Cardiovasc. Res. 101, 203\u2013210 (2014).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2015169_CR137","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.4049\/jimmunol.113.6.1726","volume":"113","author":"JF Woodruff","year":"1974","unstructured":"Woodruff, J. F. & Woodruff, J. J. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease. J. Immunol. 113, 1726\u20131734 (1974).","journal-title":"J. Immunol."},{"key":"BFnrcardio2015169_CR138","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.0105-2896.2006.00412.x","volume":"212","author":"BT Rouse","year":"2006","unstructured":"Rouse, B. T., Sarangi, P. P. & Suvas, S. Regulatory T cells in virus infections. Immunol. Rev. 212, 272\u2013286 (2006).","journal-title":"Immunol. Rev."},{"key":"BFnrcardio2015169_CR139","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/08916930600758035","volume":"39","author":"L Wei","year":"2006","unstructured":"Wei, L., Wei-Min, L., Cheng, G. & Bao-Guo, Z. Upregulation of CD4+CD25+ T lymphocyte by adenovirus-mediated gene transfer of CTLA4Ig fusion protein in experimental autoimmune myocarditis. Autoimmunity 39, 289\u2013298 (2006).","journal-title":"Autoimmunity"},{"key":"BFnrcardio2015169_CR140","doi-asserted-by":"publisher","first-page":"e28513","DOI":"10.1371\/journal.pone.0028513","volume":"6","author":"K Miteva","year":"2011","unstructured":"Miteva, K. et al. Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis. PLoS ONE 6, e28513 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrcardio2015169_CR141","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2249.2012.04598.x","volume":"169","author":"P Chen","year":"2012","unstructured":"Chen, P. et al. Susceptibility to autoimmune myocarditis is associated with intrinsic differences in CD4(+) T cells. Clin. Exp. Immunol. 169, 79\u201388 (2012).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrcardio2015169_CR142","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1161\/CIRCULATIONAHA.109.893248","volume":"121","author":"Y Shi","year":"2010","unstructured":"Shi, Y. et al. Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway. Circulation 121, 2624\u20132634 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio2015169_CR143","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/01.RES.0000249405.13536.49","volume":"99","author":"SA Huber","year":"2006","unstructured":"Huber, S. A., Feldman, A. M. & Sartini, D. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice. Circ. Res. 99, 1109\u20131116 (2006).","journal-title":"Circ. Res."},{"key":"BFnrcardio2015169_CR144","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.4049\/jimmunol.176.8.4748","volume":"176","author":"M Ono","year":"2006","unstructured":"Ono, M., Shimizu, J., Miyachi, Y. & Sakaguchi, S. Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells. J. Immunol. 176, 4748\u20134756 (2006).","journal-title":"J. Immunol."},{"key":"BFnrcardio2015169_CR145","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/cvr\/cvs077","volume":"94","author":"AP Papageorgiou","year":"2012","unstructured":"Papageorgiou, A. P. et al. Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells. Cardiovasc. Res. 94, 115\u2013124 (2012).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2015169_CR146","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1096\/fj.13-229351","volume":"27","author":"JF Vasconcelos","year":"2013","unstructured":"Vasconcelos, J. F. et al. Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy. FASEB J. 27, 4691\u20134702 (2013).","journal-title":"FASEB J."},{"key":"BFnrcardio2015169_CR147","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.lfs.2014.01.007","volume":"118","author":"K Tajiri","year":"2014","unstructured":"Tajiri, K. et al. Endothelin receptor antagonist exacerbates autoimmune myocarditis in mice. Life Sci. 118, 288\u2013296 (2014).","journal-title":"Life Sci."},{"key":"BFnrcardio2015169_CR148","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.virol.2011.09.006","volume":"421","author":"Y Xie","year":"2011","unstructured":"Xie, Y. et al. The role of Th17 cells and regulatory T cells in Coxsackievirus B3-induced myocarditis. Virology 421, 78\u201384 (2011).","journal-title":"Virology"},{"key":"BFnrcardio2015169_CR149","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1161\/01.RES.82.10.1035","volume":"82","author":"Y Okura","year":"1998","unstructured":"Okura, Y. et al. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Circ. Res. 82, 1035\u20131042 (1998).","journal-title":"Circ. Res."},{"key":"BFnrcardio2015169_CR150","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/eurjhf\/hfr014","volume":"13","author":"M Noutsias","year":"2011","unstructured":"Noutsias, M. et al. Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy. Eur. J. Heart Fail. 13, 611\u2013618 (2011).","journal-title":"Eur. J. Heart Fail."},{"key":"BFnrcardio2015169_CR151","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/01.RES.81.4.627","volume":"81","author":"T Kubota","year":"1997","unstructured":"Kubota, T. et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ. Res. 81, 627\u2013635 (1997).","journal-title":"Circ. Res."},{"key":"BFnrcardio2015169_CR152","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.yjmcc.2004.01.008","volume":"36","author":"Z Tang","year":"2004","unstructured":"Tang, Z. et al. Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis. J. Mol. Cell. Cardiol. 36, 515\u2013530 (2004).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnrcardio2015169_CR153","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.cca.2010.08.013","volume":"411","author":"N Li","year":"2010","unstructured":"Li, N. et al. The Th17\/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with reduced ejection fraction. Clin. Chim. Acta 411, 1963\u20131968 (2010).","journal-title":"Clin. Chim. Acta"},{"key":"BFnrcardio2015169_CR154","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/hrt.2009.184945","volume":"96","author":"H Tang","year":"2010","unstructured":"Tang, H. et al. Low responder T cell susceptibility to the suppressive function of regulatory T cells in patients with dilated cardiomyopathy. Heart 96, 765\u2013771 (2010).","journal-title":"Heart"},{"key":"BFnrcardio2015169_CR155","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/sji.12000","volume":"77","author":"D Bulut","year":"2013","unstructured":"Bulut, D., Creutzenberg, G. & Mugge, A. The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy. Scand. J. Immunol. 77, 54\u201361 (2013).","journal-title":"Scand. J. Immunol."},{"key":"BFnrcardio2015169_CR156","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/eurjhf\/hft054","volume":"15","author":"R Pistulli","year":"2013","unstructured":"Pistulli, R. et al. Decrease in dendritic cells in endomyocardial biopsies of human dilated cardiomyopathy. Eur. J. Heart Fail. 15, 974\u2013985 (2013).","journal-title":"Eur. J. Heart Fail."},{"key":"BFnrcardio2015169_CR157","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1093\/eurheartj\/ehq392","volume":"32","author":"A Barsheshet","year":"2011","unstructured":"Barsheshet, A. et al. Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarction. Eur. Heart J. 32, 1614\u20131621 (2011).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2015169_CR158","doi-asserted-by":"publisher","first-page":"e74955","DOI":"10.1371\/journal.pone.0074955","volume":"8","author":"Y Cao","year":"2013","unstructured":"Cao, Y., Xu, W. & Xiong, S. Adoptive transfer of regulatory T cells protects against Coxsackievirus B3-induced cardiac fibrosis. PLoS ONE 8, e74955 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrcardio2015169_CR159","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1159\/000303050","volume":"25","author":"TT Tang","year":"2010","unstructured":"Tang, T. T. et al. Defective circulating CD4CD25+Foxp3+CD127(low) regulatory T-cells in patients with chronic heart failure. Cell Physiol. Biochem. 25, 451\u2013458 (2010).","journal-title":"Cell Physiol. Biochem."},{"key":"BFnrcardio2015169_CR160","doi-asserted-by":"publisher","first-page":"e24272","DOI":"10.1371\/journal.pone.0024272","volume":"6","author":"TT Tang","year":"2011","unstructured":"Tang, T. T. et al. Impaired thymic export and apoptosis contribute to regulatory T-cell defects in patients with chronic heart failure. PLoS ONE 6, e24272 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrcardio2015169_CR161","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1536\/ihj.13-343","volume":"55","author":"N Okamoto","year":"2014","unstructured":"Okamoto, N. et al. Prognostic value of circulating regulatory T cells for worsening heart failure in heart failure patients with reduced ejection fraction. Int. Heart J. 55, 271\u2013277 (2014).","journal-title":"Int. Heart J."},{"key":"BFnrcardio2015169_CR162","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10875-009-9332-6","volume":"30","author":"L Guilherme","year":"2010","unstructured":"Guilherme, L. & Kalil, J. Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J. Clin. Immunol. 30, 17\u201323 (2010).","journal-title":"J. Clin. Immunol."},{"key":"BFnrcardio2015169_CR163","first-page":"118","volume":"22","author":"S Mukhopadhyay","year":"2013","unstructured":"Mukhopadhyay, S. et al. Regulatory T-cell deficiency in rheumatic heart disease: a preliminary observational study. J. Heart Valve Dis. 22, 118\u2013125 (2013).","journal-title":"J. Heart Valve Dis."},{"key":"BFnrcardio2015169_CR164","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2310\/JIM.0000000000000023","volume":"62","author":"HD Bas","year":"2014","unstructured":"Bas, H. D. et al. A shift in the balance of regulatory T and T helper 17 cells in rheumatic heart disease. J. Investig. Med. 62, 78\u201383 (2014).","journal-title":"J. Investig. Med."},{"key":"BFnrcardio2015169_CR165","first-page":"461","volume":"16","author":"A Yildiz","year":"2007","unstructured":"Yildiz, A. et al. Circulating CD4+CD25+ T cells in rheumatic mitral stenosis. J. Heart Valve Dis. 16, 461\u2013467 (2007).","journal-title":"J. Heart Valve Dis."},{"key":"BFnrcardio2015169_CR166","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1111\/jcmm.12304","volume":"18","author":"D Brea","year":"2014","unstructured":"Brea, D. et al. Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia. J. Cell. Mol. Med. 18, 1571\u20131579 (2014).","journal-title":"J. Cell. Mol. Med."},{"key":"BFnrcardio2015169_CR167","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12017-009-8074-1","volume":"12","author":"G Yilmaz","year":"2010","unstructured":"Yilmaz, G. & Granger, D. N. Leukocyte recruitment and ischemic brain injury. Neuromolecular Med. 12, 193\u2013204 (2010).","journal-title":"Neuromolecular Med."},{"key":"BFnrcardio2015169_CR168","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1182\/blood-2012-04-426734","volume":"121","author":"C Kleinschnitz","year":"2013","unstructured":"Kleinschnitz, C. et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 121, 679\u2013691 (2013).","journal-title":"Blood"},{"key":"BFnrcardio2015169_CR169","first-page":"1015","volume":"6","author":"Q Li","year":"2013","unstructured":"Li, Q. et al. Peripheral Th17\/Treg imbalance in patients with atherosclerotic cerebral infarction. Int. J. Clin. Exp. Pathol. 6, 1015\u20131027 (2013).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"BFnrcardio2015169_CR170","first-page":"813045","volume":"2014","author":"Y Hu","year":"2014","unstructured":"Hu, Y., Zheng, Y., Wu, Y., Ni, B. & Shi, S. Imbalance between IL-17A-producing cells and regulatory T cells during ischemic stroke. Mediators Inflamm. 2014, 813045 (2014).","journal-title":"Mediators Inflamm."},{"key":"BFnrcardio2015169_CR171","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jneuroim.2011.12.019","volume":"243","author":"J Yan","year":"2012","unstructured":"Yan, J. et al. Frequency and function of regulatory T cells after ischaemic stroke in humans. J. Neuroimmunol. 243, 89\u201394 (2012).","journal-title":"J. Neuroimmunol."},{"key":"BFnrcardio2015169_CR172","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jneuroim.2008.11.001","volume":"206","author":"J Yan","year":"2009","unstructured":"Yan, J. et al. Immune activation in the peripheral blood of patients with acute ischemic stroke. J. Neuroimmunol. 206, 112\u2013117 (2009).","journal-title":"J. Neuroimmunol."},{"key":"BFnrcardio2015169_CR173","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.4049\/jimmunol.176.11.6523","volume":"176","author":"H Offner","year":"2006","unstructured":"Offner, H. et al. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J. Immunol. 176, 6523\u20136531 (2006).","journal-title":"J. Immunol."},{"key":"BFnrcardio2015169_CR174","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ana.23815","volume":"74","author":"P Li","year":"2013","unstructured":"Li, P. et al. Adoptive regulatory T-cell therapy protects against cerebral ischemia. Ann. Neurol. 74, 458\u2013471 (2013).","journal-title":"Ann. Neurol."},{"key":"BFnrcardio2015169_CR175","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","volume":"133","author":"P Trzonkowski","year":"2009","unstructured":"Trzonkowski, P. et al. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127\u2212 T regulatory cells. Clin. Immunol. 133, 22\u201326 (2009).","journal-title":"Clin. Immunol."},{"key":"BFnrcardio2015169_CR176","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","volume":"117","author":"CG Brunstein","year":"2011","unstructured":"Brunstein, C. G. et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117, 1061\u20131070 (2011).","journal-title":"Blood"},{"key":"BFnrcardio2015169_CR177","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clim.2014.03.016","volume":"153","author":"N Marek-Trzonkowska","year":"2014","unstructured":"Marek-Trzonkowska, N. et al. Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets\u2014results of one year follow-up. Clin. Immunol. 153, 23\u201330 (2014).","journal-title":"Clin. Immunol."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.169","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T18:34:34Z","timestamp":1692124474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,3]]},"references-count":177,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFnrcardio2015169"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2015.169","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,3]]},"assertion":[{"value":"3 November 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}